Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

REporting recommendations for tumour MARKer prognostic studies (REMARK).

L M McShane1, D G Altman, W Sauerbrei

  • 1US National Cancer Institute, Bethesda, MD 20892, USA. Lm5h@nih.gov

British Journal of Cancer
|August 18, 2005
PubMed
Summary

Clinical utility of cancer tumor markers is limited due to inconsistent research findings. New guidelines promote transparent reporting of tumor marker studies to improve reliability and reproducibility.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CONSORT 2010 statement: extension checklist for reporting within person randomised trials.

The British journal of dermatology·2019
Same author

'Allocation concealment': the evolution and adoption of a methodological term.

Journal of the Royal Society of Medicine·2018
Same author

[Better Reporting of Interventions: Template for Intervention Description and Replication (TIDieR) Checklist and Guide].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2018
Same author

GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research.

Research involvement and engagement·2017
Same author

GRIPP2 reporting checklists: tools to improve reporting of patient and public involvement in research.

BMJ (Clinical research ed.)·2017
Same author

Quality control of ultrasound for fetal biometry: results from the INTERGROWTH-21<sup>st</sup> Project.

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology·2017

Area of Science:

  • Oncology
  • Biomarker Research
  • Clinical Diagnostics

Background:

  • Numerous tumor marker studies yield inconsistent or contradictory results, hindering clinical utility.
  • Methodological problems and inadequate reporting obscure the reliability and generalizability of findings.
  • There is a critical need to understand discrepancies in tumor marker research.

Framework:

  • Proposing guidelines for rigorous reporting of tumor marker studies.
  • Guidelines address study design, hypotheses, patient/specimen details, assay methods, and statistical analysis.
  • Recommendations draw inspiration from CONSORT and STARD initiatives.

Implementation:

  • Encouraging transparent and complete reporting of all relevant study information.
  • Guidelines will aid in assessing data quality and study context.

Related Experiment Videos

  • Facilitating better judgment of tumor marker usefulness.

    • Implications:

    • Enhance the reliability and reproducibility of tumor marker research.
    • Improve the clinical translation of promising cancer biomarkers.
    • Standardize reporting to facilitate meta-analyses and evidence synthesis.